Price T Rowe Associates Inc Voyager Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 905,820 shares of VYGR stock, worth $5.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

905,820

Previous 989,549 8.46%

Holding current value

$5.24 Million

Previous $7.83 Million 32.29%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.77 - $9.27 $483,116 - $776,167	-83,729 Reduced 8.46%	905,820 $5.3 Million
Q2 2024 Aug 14, 2024	SELL	$7.42 - $10.54 $388,667 - $552,095	-52,381 Reduced 5.03%	989,549 $7.83 Million
Q1 2024 May 15, 2024	BUY	$7.15 - $10.84 $265,579 - $402,640	37,144 Added 3.7%	1,041,930 $9.7 Million
Q4 2023 Feb 14, 2024	SELL	$6.28 - $8.81 $1.06 Million - $1.49 Million	-169,301 Reduced 14.42%	1,004,786 $8.48 Million
Q3 2023 Nov 14, 2023	SELL	$7.55 - $11.25 $421,999 - $628,807	-55,894 Reduced 4.54%	1,174,087 $9.1 Million
Q2 2023 Aug 14, 2023	BUY	$6.94 - $13.99 $2.28 Million - $4.6 Million	328,516 Added 36.44%	1,229,981 $14.1 Million
Q1 2023 May 15, 2023	BUY	$6.0 - $10.78 $624,864 - $1.12 Million	104,144 Added 13.06%	901,465 $6.95 Million
Q4 2022 Feb 14, 2023	SELL	$4.94 - $6.61 $229,166 - $306,637	-46,390 Reduced 5.5%	797,321 $4.86 Million
Q3 2022 Nov 14, 2022	BUY	$5.57 - $7.47 $87,788 - $117,734	15,761 Added 1.9%	843,711 $5 Million
Q2 2022 Aug 15, 2022	BUY	$4.82 - $10.09 $3.77 Million - $7.9 Million	782,850 Added 1735.81%	827,950 $4.89 Million
Q1 2022 May 16, 2022	SELL	$2.75 - $9.44 $125,950 - $432,352	-45,800 Reduced 50.39%	45,100 $344,000
Q4 2021 Feb 14, 2022	BUY	$2.47 - $5.55 $3,705 - $8,325	1,500 Added 1.68%	90,900 $246,000
Q3 2021 Nov 15, 2021	BUY	$2.63 - $4.12 $68,117 - $106,708	25,900 Added 40.79%	89,400 $235,000
Q2 2021 Aug 16, 2021	SELL	$3.94 - $5.44 $7,399 - $10,216	-1,878 Reduced 2.87%	63,500 $262,000
Q1 2021 May 17, 2021	BUY	$4.61 - $9.04 $301,392 - $591,017	65,378 New	65,378 $308,000

Others Institutions Holding VYGR

# of Institutions

130

Shares Held

34.7M

Call Options Held

39.7K

Put Options Held

34.6K

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Voyager Therapeutics, Inc. Transaction History